Leticia Corrales Pecino

Title: Leticia Corrales Pecino: Innovator in Lung Cancer Diagnosis

Introduction

Leticia Corrales Pecino is a prominent inventor based in Pamplona, Spain. She has made significant contributions to the field of biomedical research, particularly in the diagnosis and prognosis of lung cancer. Her innovative approach has the potential to improve patient outcomes through early detection and tailored medical regimens.

Latest Patents

Leticia holds a patent for her invention titled "Lung cancer molecular markers." This invention provides a method for diagnosing and/or prognosing lung cancer by determining the level of a C4 activation fragment in a test sample. The method involves comparing the level of the test sample with that of a control sample. If the level of the C4 activation fragment is higher than that in the reference control, it indicates that the subject may suffer from lung cancer or have a poor prognosis. This invention also outlines methods for assessing the risk of developing lung cancer and for evaluating the efficacy of medical treatments based on the determination of the C4 activation fragment. The use of this marker confers high sensitivity and specificity to the diagnostic methods.

Career Highlights

Leticia is associated with Proyecto De Biomedicina Cima, S.L., where she continues to advance her research in the biomedical field. Her work is characterized by a commitment to improving diagnostic techniques and patient care in oncology.

Collaborations

Leticia collaborates with esteemed colleagues, including Daniel Ajona Martínez-Polo and Luis Montuenga Badía. Their combined expertise enhances the research efforts at Proyecto De Biomedicina Cima, S.L.

Conclusion

Leticia Corrales Pecino is a trailblazer in the field of lung cancer diagnostics, with her innovative patent offering new hope for early detection and effective treatment. Her contributions are vital in the ongoing fight against cancer, showcasing the importance of research and innovation in healthcare.